Soros Fund Management - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Soros Fund Management ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$343,539,000
+87.9%
2,272,535
+81.1%
5.87%
+80.2%
Q2 2022$182,866,000–1,255,001–3.26%–
 Download
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders